ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 59 filers reported holding ODONATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $476,000 | -53.0% | 352,814 | +1.3% | 0.00% | – |
| Q3 2021 | $1,013,000 | +1.7% | 348,433 | +22.0% | 0.00% | – |
| Q2 2021 | $996,000 | -27.4% | 285,488 | -28.8% | 0.00% | – |
| Q1 2021 | $1,371,000 | -73.9% | 401,077 | +46.8% | 0.00% | -100.0% |
| Q4 2020 | $5,246,000 | +96.0% | 273,253 | +37.1% | 0.00% | 0.0% |
| Q3 2020 | $2,676,000 | -67.8% | 199,288 | +1.4% | 0.00% | -50.0% |
| Q2 2020 | $8,319,000 | +75.5% | 196,489 | +14.4% | 0.00% | +100.0% |
| Q1 2020 | $4,740,000 | -56.5% | 171,704 | -48.9% | 0.00% | 0.0% |
| Q4 2019 | $10,902,000 | +156.0% | 335,972 | +105.3% | 0.00% | 0.0% |
| Q3 2019 | $4,259,000 | -10.1% | 163,644 | +26.8% | 0.00% | 0.0% |
| Q2 2019 | $4,735,000 | +100.1% | 129,068 | +20.6% | 0.00% | 0.0% |
| Q1 2019 | $2,366,000 | -10.4% | 107,032 | -43.0% | 0.00% | – |
| Q4 2018 | $2,642,000 | +87.4% | 187,684 | +158.3% | 0.00% | – |
| Q3 2018 | $1,410,000 | -9.1% | 72,674 | +3.4% | 0.00% | – |
| Q2 2018 | $1,551,000 | +18.1% | 70,274 | +13.3% | 0.00% | – |
| Q1 2018 | $1,313,000 | – | 62,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |